Tonghua Jinma announced that succinyl octahydroaminoacridine tablets are a novel, potent cholinesterase inhibitor with a clear mechanism of action. It is a new chemical class 1 drug with completely independent intellectual property rights and a new chemical molecular structure, and is used to treat mild and moderate Alzheimer's disease.

Zhitongcaijing · 10/15 08:57
Tonghua Jinma announced that succinyl octahydroaminoacridine tablets are a novel, potent cholinesterase inhibitor with a clear mechanism of action. It is a new chemical class 1 drug with completely independent intellectual property rights and a new chemical molecular structure, and is used to treat mild and moderate Alzheimer's disease.